Merus Funding: $500M Raised, IPO

Merus funding overview

Merus is based in Weston, MA. Merus has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO. Investors on record include Bay City Capital, LSP (Life Sciences Partners), Johnson & Johnson Innovation, Pfizer Venture Investments, Novartis Venture Fund. 5 distinct backers are named across the disclosed rounds.

Merus at a glance

Total raised: $500M
Latest round: IPO
Headquarters: Weston, MA
Notable investors: Bay City Capital, LSP (Life Sciences Partners), Johnson & Johnson Innovation, Pfizer Venture Investments, Novartis Venture Fund

Frequently asked about Merus funding

How much has Merus raised?: Merus has raised $500M in total disclosed funding across the rounds on record.
Who has invested in Merus?: Bay City Capital, LSP (Life Sciences Partners), Johnson & Johnson Innovation, Pfizer Venture Investments, Novartis Venture Fund are named among the investors backing Merus.
What was the latest Merus funding round?: The most recent disclosed round is an IPO.
Where is Merus based?: Merus is based in Weston, MA.

Round data for Merus is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Weston and backer lists below.

Merus Funding: $500M Raised, IPO

Merus funding overview

Merus at a glance

Frequently asked about Merus funding

Companies related to Merus (34)

Browse related funding lists (5)